March « 2023 « Science and Enterprise

Speeding Up Your Start-Up

By Alan, on March 27th, 2023%

We’ll look at five tips on how to expedite the startup process, including the option of opening a franchise. . . . → Read More: Speeding Up Your Start-Up

Infographic – Six Generative A.I. Applications

By Alan, on March 25th, 2023%

Chart: Six industrial applications of generative A.I.

As our infographic indicates, generative A.I. can be applied in a range of industries, particularly in design and discovery functions. . . . → Read More: Infographic – Six Generative A.I. Applications

Screening Device Company Kicks-Off Type 1 Diabetes Network

By Alan, on March 24th, 2023%

A developer of a blood-testing device that screens for kidney disease risks is the first company to join a network to advance new technology for type 1 diabetes. . . . → Read More: Screening Device Company Kicks-Off Type 1 Diabetes Network

Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

By Alan, on March 23rd, 2023%

Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Start-Up Licenses Protein Therapy Tech, Raises $50M

By Alan, on March 22nd, 2023%

A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M

Trial to Test Low-Dose Psilocybin for Mental Distress

By Alan, on March 21st, 2023%

A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin. . . . → Read More: Trial to Test Low-Dose Psilocybin for Mental Distress

HPV Vaccine Generates Immune Responses in Trial

By Alan, on March 20th, 2023%

Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions. . . . → Read More: HPV Vaccine Generates Immune Responses in Trial

Infographic – A.I. Venture Funds Tick Up in Q4 2022

By Alan, on March 18th, 2023%

Chart: Venture funding in A.I. by quarter

A new report on venture funding for artificial intelligence start-ups shows global investment dollars rose in the fourth quarter of 2022, the first increase in 18 months. . . . → Read More: Infographic – A.I. Venture Funds Tick Up in Q4 2022

Standard Electronic Biomarkers Validated for Schizophrenia

By Alan, on March 17th, 2023%

A new study validates standard electronic instrument measures of healthy individuals and people with schizophrenia to enable reliable clinical trials for treating the disease. . . . → Read More: Standard Electronic Biomarkers Validated for Schizophrenia

Post-Surgical Fluid Cancer Analytics Company Gains $8M

By Alan, on March 16th, 2023%

A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds. . . . → Read More: Post-Surgical Fluid Cancer Analytics Company Gains $8M

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise